Amyotrophic Lateral Sclerosis Clinical Trials in Houston, Texas

4 studies are recruiting for amyotrophic lateral sclerosis in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

    The goal of this clinical trial is to learn if the drug pridopidine works to treat amyotrophic lateral sclerosis in adults. It will also help to learn about the safety of pridopidine. The main question it aims to answer is: Does pridopidine slow disease progression of ALS? Researchers will compare …

    Stage
    Phase 3
    Ages
    18 to 80
    Site
    Baylor College of Medicine; McNair Medical Campus, Houston, Texas
    Locations
    55 in total
    Run by
    Prilenia

    See if you can join NCT07322003 on ClinicalTrials.gov

  2. ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

    ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Nantz National Alzheimer Center Houston, Houston, Texas
    Locations
    27 in total
    Run by
    Mayo Clinic

    See if you can join NCT04363684 on ClinicalTrials.gov

  3. BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

    The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Baylor College of Medicine, Houston, Texas
    Locations
    6 in total
    Run by
    Leigh R. Hochberg, MD, PhD.

    See if you can join NCT00912041 on ClinicalTrials.gov

  4. Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

    The goal of the study is to generate a biorepository of longitudinal biofluids-blood (plasma and serum), cerebral spinal fluid (CSF) and urine linked to genetics and longitudinal clinical information that are made available to the research community. To accomplish these goals, we will enroll 800 Am…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Baylor College of Medicine, Houston, Texas
    Locations
    12 in total
    Run by
    Target ALS Foundation, Inc.

    See if you can join NCT05137665 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.